Our Caring

At Janssen, we are committed to helping people living with HIV in resource-limited settings by ensuring effective and sustainable access to our HIV medicines, or antiretrovirals (ARVs). We believe that effective HIV drug access has two important components: ensuring quality and affordable medicines are available sustainably and that they are used safely and in the most appropriate way for people living with HIV/AIDS (PLWHA).

Through our comprehensive HIV drug access framework (Read our Framework PDF), our Global Access and Partnerships Program (GAPP) works to fulfill our responsibility to provide access to our medicines, specifically in least-developed countries and lower middle-income countries (LDCs and LMICs). The program includes:

We invite you to learn more by viewing the Janssen Global Access & Partnerships Program Overview: HIV Medicine Access brochure (PDF).